Project Details
Description
DESCRIPTION: There is recent evidence to suggest that ELF-MF may function
as a tumor promoter, and as a co-mutagen with radiation and chemical
carcinogens. Preliminary studies by the applicant have shown a 2-3 fold
enhancement in the mutagenicity of the direct alkylating agent MNNG, by
magnetic fields. The present project proposes to extend these findings by
examining the combined mutagenic effects of ELF-MF with either gamma-rays or
benzopyrene, at both the cellular and molecular levels. Mutation will be
scored at both the S1 and HGPRT loci using the human-hamster hybrid AL
cells. Quantitative mutagenesis data will be used in assessing the mode of
interaction between ELF-MF and the other two known human carcinogens.
Molecular spectra will be used to ascertain the presence or absence of
specific signature changes at the gene level. The molecular basis for
mutations in the AL cells will be examined, both by using specific DNA
probes of other genes that have been regionally mapped to various sites on
chromosome 11, and by Southern blot analysis of hprt mutants.
Status | Finished |
---|---|
Effective start/end date | 1/30/97 → 12/31/98 |
Funding
- National Institute of Environmental Health Sciences
ASJC Scopus Subject Areas
- Cell Biology
- Radiation
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.